RNAi nanomedicines: challenges and opportunities within the immune system
Author:
Publisher
IOP Publishing
Subject
Electrical and Electronic Engineering,Mechanical Engineering,Mechanics of Materials,General Materials Science,General Chemistry,Bioengineering
Link
http://stacks.iop.org/0957-4484/21/i=23/a=232001/pdf
Reference109 articles.
1. RNA interference in biology and disease
2. Interfering with disease: a progress report on siRNA-based therapeutics
3. MicroRNA: an Emerging Therapeutic Target and Intervention Tool
4. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
5. Approaches for chemically synthesized siRNA and vector-mediated RNAi
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting Inflammasome Activation in COVID-19: Delivery of RNA Interference-Based Therapeutic Molecules;Biomedicines;2021-12-03
2. miRNA nanotherapeutics: potential and challenges in respiratory disorders;Future Medicinal Chemistry;2020-06
3. Improving the therapeutic efficiency of noncoding RNAs in cancers using targeted drug delivery systems;Drug Discovery Today;2020-04
4. A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes;Advanced Materials;2020-03
5. Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes;Advanced Drug Delivery Reviews;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3